FDA clears Imaging Biometrics MR perfusion software
Imaging Biometrics, a provider of advanced visualization and analytical software solutions, has received 510(k) clearance from the FDA for its new MRI perfusion software, IB Neuro.
By incorporating proprietary computational algorithms, IB said its IB Neuro allows clinicians to make informed decisions in their approach to MRI perfusion imaging of brain tumors and other brain disorders.
“IB Neuro showed a statistically significant ability to consistently differentiate between normal and abnormal brain tissue, whereas all the other techniques to which IB Neuro was compared did not,” said Michael Schmainda, IB’s president and CEO.
IB Neuro generates and displays an array of perfusion parameter colormaps in seconds, the Milwaukee-based company said.
By incorporating proprietary computational algorithms, IB said its IB Neuro allows clinicians to make informed decisions in their approach to MRI perfusion imaging of brain tumors and other brain disorders.
“IB Neuro showed a statistically significant ability to consistently differentiate between normal and abnormal brain tissue, whereas all the other techniques to which IB Neuro was compared did not,” said Michael Schmainda, IB’s president and CEO.
IB Neuro generates and displays an array of perfusion parameter colormaps in seconds, the Milwaukee-based company said.